Nature

Research round-up: autoimmune disease

For decades, clinical observations have suggested that the prevalence of autoimmune disease is increasing. However, studies based on systematic data are limited, so it has been unclear whether the ...
EurekAlert!

B cell targeted CAR-T therapy for autoimmune diseases

Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a transformative approach in modern medicine, demonstrating remarkable efficacy in targeting pathogenic B-cell lineages with ...
National Academies of Sciences%2c Engineering%2c and Medicine

Enhancing NIH Research on Autoimmune Disease

Suggested Citation: "2 Background on Autoimmune Diseases." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National ...

CAR T moves beyond cancer, targeting autoimmune disease with immune system reset

At age 49, Jan Janisch-Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a desk role. Frequent falls made her afraid to carry ...
Business Insider

Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid ...

Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no ...
Finanznachrichten

Artiva Biotherapeutics, Inc.: Artiva Announces Positive Initial Clinical Data with AlloNK Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 ...

Initial clinical data demonstrated 71% ACR50 response in refractory rheumatoid arthritis (RA) patients with at least six months of follow-up in the company-sponsored Phase 2a basket trial, with no ...